Aequs Q4 FY26 Results Analysis: Aerospace EBITDA Margin Surges to 33%, Net Loss at Rs.537 Mn

CompoundingAI Research Updated May 26, 2026 2 min read
Negative

Aequs Ltd's Q4 FY26 numbers came in soft. Here's a quick read of what worked, what to watch, and what management said.

Quick Details
Results dateMay 26, 2026
QuarterQ4 FY 2025-2026
Revenue (Q4)Rs. 367.10 Cr (+47.27% YoY)
PAT (Q4)Rs. -53.72 Cr
EBITDA margin8.75% (-795 bps YoY)
EPS (Q4)Rs. -0.89
Market capRs. 14,243.67 Cr
CMPRs. 212.48

Quarter Snapshot

Aerospace delivered a standout 33% EBITDA margin, beating management's 20%+ target, but the consumer segment drag and surging finance/D&A costs pushed the consolidated result to a net loss of Rs.537 Mn. The IPO has transformed the balance sheet (equity doubled, leverage halved), but the path to group-level profitability hinges on consumer segment utilization improvement.

Key Investment Insights

Key Positives

  • Aerospace segment EBITDA margin reached 33.23% in Q4, up from 20.54% a year ago and well above management's 20%+ target
  • Consolidated revenue grew 47.3% YoY to Rs.3,671 Mn, with aerospace revenue up 28.8% YoY
  • IPO proceeds strengthened the balance sheet — total equity rose 107% to Rs.14,855 Mn and Debt/Equity improved to 0.27x from 0.61x
  • Consumer segment revenue surged 375.6% YoY, increasing its share of total revenue to 17.2%
  • Cash balance increased from Rs.609 Mn to Rs.3,015 Mn following the IPO, providing ample liquidity

Risk Factors

  • Consolidated net loss widened to Rs.537 Mn in Q4 from a profit of Rs.89 Mn a year ago
  • Finance costs surged 169% YoY to Rs.358 Mn and D&A rose 88% YoY to Rs.455 Mn, together consuming Rs.1,300 Mn in Q4
  • Consumer segment EBITDA loss widened to Rs.473 Mn (margin -75%), far from the 18-20% target
  • Operating cash flow was negative at Rs.988 Mn for FY26, driven by working capital build-up of Rs.2,594 Mn
  • CFO resignation effective June 30, 2026 introduces leadership uncertainty
Share on X · LinkedIn · WhatsApp

Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.

Powered by CompoundingAI — AI research platform for Indian stocks, every claim cited from primary filings

Login Now